ABCDx is a Spain-based Health Care startup that aims to transform stroke management through their innovative mobile brain diagnostic platform. By leveraging the power of smartphones to serve as medical devices, ABCDx empowers healthcare providers with accessible tools to swiftly and accurately diagnose stroke patients at point-of-care, all within a matter of minutes. Their pioneering method involves decoding brain biomarkers, enabling the detection of brain injury with just a single drop of blood from a finger prick. Founded in 2014, the company received its latest funding through a Venture Round investment on 19 December 2022, with the European Innovation Council participating as investors. For those interested in joining this breakthrough in mobile brain diagnostics, the team can be contacted through their website: https://www.abcdx.es/contact.
No recent news or press coverage available for ABCDx SA.